StockWatch
·
HomeLiveReports
Pharmaceuticals
Board Meeting28 Oct 2026, 02:48 pm

Medi Caps Ltd Board Meeting on Nov 4 to Approve Q2 FY27 Results

AI Summary

Medi Caps Ltd has announced that its Board of Directors will convene on November 4, 2026, to consider and approve the standalone and consolidated un-audited financial results for the quarter and half-year ended September 30, 2026. A limited review report will also be presented. Following the declaration of these results, the trading window for designated persons and connected individuals will reopen 48 hours later, in accordance with SEBI (Prohibition of Insider Trading) Regulations, 2015.

Key Highlights

  • Board meeting scheduled for November 4, 2026.
  • To approve standalone and consolidated un-audited financial results.
  • Results for the quarter and half-year ended September 30, 2026.
  • Trading window to reopen 48 hours after results announcement.
View BSE Filing
MEDICAPQ
Pharmaceuticals
MEDI-CAPS LTD.-$

Price Impact

More from MEDICAPQ

Corporate Governance25 Sept, 3:53 pm

Medi Caps Ltd: Trading Window Closure for Financial Results

AGM/EGM23 Sept, 4:03 pm

Medi Caps Ltd: AGM Approves Re-appointment of CMD, Director Appointment

AGM/EGM23 Sept, 3:44 pm

Medi Caps Ltd: AGM Voting Results Approved by Shareholders

More in Board Meeting

PATELENG25m ago

Patel Engineering Board Meeting on Nov 5, 2026 for Q2 FY27 Results

KKPLASTICK25m ago

Kkalpana Plastick: Board Approves Un-audited Results, Change in Management

GKB25m ago

GKB Ophthalmics Board Meeting on Nov 12 to Approve Unaudited Results